OR WAIT null SECS
November 10, 2020
FDA issued emergency use authorization for bamlanivimab for patients at risk for severe COVID-19.
November 09, 2020
Interim efficacy data suggests the Pfizer/BioNTech has an efficacy rate above 90%.
November 06, 2020
Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.
November 03, 2020
The agreement will provide capacity for the manufacturing of AZD7442, currently being developed for the potential prevention and treatment of COVID-19, at Lonza's Portsmouth, NH site.
October 21, 2020
Joerg Ahlgrimm is now leading The Discovery Labs’ mission to establish a powerhouse for cell and gene therapy development and manufacturing in the Philadelphia area.
October 20, 2020
Orgenesis has completed its previously announced acquisition of Koligo Therapeutics with the additional acquisition of Tissue Genesis’ cell isolation technology, Icellator.
Branching out from roots in industrial biotechnology, Riffyn Data Systems (and its CEO Tim Gardner) is taking the message of data-driven process improvement to biopharma.
October 16, 2020
For planned acquisitions or licensing, a careful analysis of CMCl factors is vital to ensure no problem areas are overlooked.
October 14, 2020
Recent data, from BIA and Clarivate, has revealed that investment in UK biotech continues to be strong.
October 02, 2020
European pharma companies may have a vested interest in the outcome of the US elections.